Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cell Reports|October 19, 2017
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in CancerLiqin Wang, Rodrigo Leite de Oliveira, Cun Wang, et al.
Cell Reports|September 15, 2015
PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer DrugsAnirudh Prahallad, Guus J J E Heynen, Giovanni Germano, et al.
Nature Communications|June 24, 2022
DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound Pol IIBarbara Steurer, Roel C Janssens, Marit E Geijer, et al.
Nucleic Acids Research|September 15, 2022
Double-strand break toxicity is chromatin context independentAnoek Friskes, Lisa Koob, Lenno Krenning, et al.
Cancer Cell|November 14, 2006
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesisPatrick W B Derksen, Xiaoling Liu, Francis Saridin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatinBastiaan Evers, Rinske Drost, Eva Schut, et al.
Oncogene|May 16, 2018
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitorsKatrien Berns, Joseph J Caumanns, E Marielle Hijmans, et al.
Atherosclerosis|July 18, 2009
Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient miceLianne S M Boesten, A Susanne M Zadelaar, Anita van Nieuwkoop, et al.
Cancer Research|August 24, 2016
The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical ModelsLenka Oplustil O'Connor, Stuart L Rulten, Aaron N Cranston, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2013
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasisChristophe J Desmet, Tristan Gallenne, Alexandre Prieur, et al.
Pageof 3